Business
Stem Cell Therapy
Organoid
Stem Cell and CDMO Business
R&D
Core Technology
Capacity
36,000 vials per year (based on finished drug products)
Dedicated HVAC
10 aseptic processing rooms and 3 aseptic laboratories Independent, dedicated HVAC systems for each area
Efficient Cell Culture Systems
Cell culture systems capable of manufacturing from small-scale to large-scale production
Reliable Manufacturing Support Utilities
Dedicated dual power supply system to enhance power Stability. Uninterruptible Power Supply (UPS) systems in place
Cross-Contamination Prevention System
Air-tight doors installed to prevent cross-contamination between manufacturing rooms. Validated hydrogen peroxide (H₂O₂) fumigation system in operation
Regulatory Approvals & Certifications
Cell Processing Facility License (MFDS), Advanced Biopharmaceutical Manufacturing License (MFDS), Human Cells and Tissues Management Business License (MFDS), Specified Cell Processing Product Manufacturing Certification (PMDA, Japan)
LIMS
Operation of LIMS and barcode systems to enhance data integrity
Real time monitoring
Real-time monitoring systems for critical process parameters
Pharmaceutical transportation
Over 1,000 cumulative deliveries of clinical investigational products completed (as of December 2025; including refrigerated and frozen shipments)